The asthma microbiome is increasingly recognised as a key factor in asthma, a chronic respiratory condition marked by wheeze, breathlessness, and airway inflammation. However, most evidence guiding asthma treatment comes from high-income countries. A new international study suggests that while airway bacteria and inflammation vary widely across regions, some microbiome–inflammation links in asthma are surprisingly consistent worldwide.
Read more
